Quanterix Announces Landmark Nature Study Redefining Alzheimer’s Disease Neuropathology Prevalence

Go back to Quanterix Announces Landmark Nature Study Redefining Alzheimer’s Disease Neuropathology Prevalence
(NASDAQ: QTRX) Delayed: 3.16 -0.03 (0.94%)
Previous Close $3.19    52 Week High
Open $3.17    52 Week Low
Day High $3.20    P/E N/A 
Day Low $3.03    EPS
Volume 423,782